ORION OYJ*ORION CORPORATION

Y-tunnus 1999212-6 · 6 myöntöä EU FTS -lähteistä

Yrityksen profiili yritysvahdissa →

Rahoitus vuosittain

Myönnöt

• 101057816 - TRANSPHARM - TRANSFORMING INTO A SUSTAINABLE EUROPEAN PHARMACEUTICAL SECTOREuroopan komissio · Horizon Europe (HADEA)
  EU FTS · Helsinki-Uusimaa
  · 2023
• 101057816 - TRANSPHARM - TRANSFORMING INTO A SUSTAINABLE EUROPEAN PHARMACEUTICAL SECTOREuroopan komissio · Horizon Europe (HADEA)
  EU FTS · Helsinki-Uusimaa
  · 2022
• 101057816 - TRANSPHARM - TRANSFORMING INTO A SUSTAINABLE EUROPEAN PHARMACEUTICAL SECTOREuroopan komissio · Horizon Europe (HADEA)
  EU FTS · Helsinki-Uusimaa
  · 2022
• 101057816 - TRANSPHARM - TRANSFORMING INTO A SUSTAINABLE EUROPEAN PHARMACEUTICAL SECTOREuroopan komissio · Horizon Europe (HADEA)
  EU FTS · Helsinki-Uusimaa
  · 2022
• 732386 - TREATER - CLINICAL STUDY IN PARKINSON'S DISEASE WITH TWO UNIQUE GOALS: 1) PROOF-OF-CONCEPT OF CDNF PROTEIN FOR DISEASE MODIFICATION; 2) VALIDATION OF CLINICALLY TESTED DEVICE FOR INTRACEREBRAL DRUG DELIVERYEuroopan komissio · Horizon 2020 (RTD)
  EU FTS · Helsinki-Uusimaa
  47 117 € · 2016
• 732386 - TREATER - CLINICAL STUDY IN PARKINSON'S DISEASE WITH TWO UNIQUE GOALS: 1) PROOF-OF-CONCEPT OF CDNF PROTEIN FOR DISEASE MODIFICATION; 2) VALIDATION OF CLINICALLY TESTED DEVICE FOR INTRACEREBRAL DRUG DELIVERYEuroopan komissio · Horizon 2020 (RTD)
  EU FTS · Helsinki-Uusimaa
  1 633 € · 2016

Lähde: Euroopan komissio / Financial Transparency System